152 related articles for article (PubMed ID: 30182269)
1. The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project.
Teare HJA; de Masi F; Banasik K; Barnett A; Herrgard S; Jablonka B; Postma JWM; McDonald TJ; Forgie I; Chmura PJ; Rydzka EK; Gupta R; Brunak S; Pearson E; Kaye J
Life Sci Soc Policy; 2018 Sep; 14(1):20. PubMed ID: 30182269
[TBL] [Abstract][Full Text] [Related]
2. Brain delivery research in public-private partnerships: The IMI-JU COMPACT consortium as an example.
Meyer AH; Untucht C; Terstappen GC
Neuropharmacology; 2017 Jul; 120():8-10. PubMed ID: 27318272
[TBL] [Abstract][Full Text] [Related]
3. Participating in innovative medicines initiative funded neurodegenerative disorder projects-An impact analysis conducted as part of the NEURONET project.
Hawksworth C; Salih F; Cresswell K; Steukers L; Diaz C; Killin L; Pradier L; Bradshaw A; Dawoud D
Front Neurol; 2023; 14():1140722. PubMed ID: 37006486
[TBL] [Abstract][Full Text] [Related]
4. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
[TBL] [Abstract][Full Text] [Related]
5. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
6. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
Coghlan R; Stephens P; Mwale B; Siyanga M
Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
[TBL] [Abstract][Full Text] [Related]
7. Governance and oversight of researcher access to electronic health data: the role of the Independent Scientific Advisory Committee for MHRA database research, 2006-2015.
Waller P; Cassell JA; Saunders MH; Stevens R
J R Coll Physicians Edinb; 2017 Mar; 47(1):24-29. PubMed ID: 28569278
[TBL] [Abstract][Full Text] [Related]
8. The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks.
O'Rourke D; Coll-Padrós N; Bradshaw A; Killin L; Pradier L; Georges J; Dawoud DM; Steukers L; Diaz C
Front Neurol; 2022; 13():994301. PubMed ID: 36408524
[TBL] [Abstract][Full Text] [Related]
9. Stimulating Research and Development of New Antibiotics While Ensuring Sustainable Use and Access: Further Insights from the DRIVE-AB Project and Others.
Bettiol E; Hackett J; Harbarth S
J Law Med Ethics; 2018 Jun; 46(1_suppl):5-8. PubMed ID: 30146955
[TBL] [Abstract][Full Text] [Related]
10. The European Prevention of Alzheimer's Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia.
Saunders S; Gregory S; Clement MHS; Birck C; van der Geyten S; Ritchie CW
Front Neurol; 2022; 13():1051543. PubMed ID: 36484017
[TBL] [Abstract][Full Text] [Related]
11. Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer's disease and other neuropsychiatric disorders.
North H; Hofmann-Apitius M; Kas MJH; Marston H; Haas M
Front Neurol; 2023; 14():1174079. PubMed ID: 37521302
[TBL] [Abstract][Full Text] [Related]
12. The Innovative Medicines Initiative moves translational immunology forward.
Goldman M; Wittelsberger A; De Magistris MT
Eur J Immunol; 2013 Feb; 43(2):298-302. PubMed ID: 23534061
[TBL] [Abstract][Full Text] [Related]
13. 'Pop-Up' Governance: developing internal governance frameworks for consortia: the example of UK10K.
Kaye J; Muddyman D; Smee C; Kennedy K; Bell J;
Life Sci Soc Policy; 2015; 11():10. PubMed ID: 26412243
[TBL] [Abstract][Full Text] [Related]
14. Data Integration for Future Medicine (DIFUTURE).
Prasser F; Kohlbacher O; Mansmann U; Bauer B; Kuhn KA
Methods Inf Med; 2018 Jul; 57(S 01):e57-e65. PubMed ID: 30016812
[TBL] [Abstract][Full Text] [Related]
15. Public-private partnership models in France and in Europe.
Demotes-Mainard J; Canet E; Segard L
Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948
[TBL] [Abstract][Full Text] [Related]
16. The innovative medicines initiative: a European response to the innovation challenge.
Goldman M
Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
[TBL] [Abstract][Full Text] [Related]
17. StemBANCC: Governing Access to Material and Data in a Large Stem Cell Research Consortium.
Morrison M; Klein C; Clemann N; Collier DA; Hardy J; Heisserer B; Cader MZ; Graf M; Kaye J
Stem Cell Rev Rep; 2015 Oct; 11(5):681-7. PubMed ID: 26024842
[TBL] [Abstract][Full Text] [Related]
18. How to Harness Big Data for the Benefit of Patients.
Meulien P
Stud Health Technol Inform; 2019; 258():2. PubMed ID: 30942701
[TBL] [Abstract][Full Text] [Related]
19. Sharing data for future research-engaging participants' views about data governance beyond the original project: a DIRECT Study.
Shah N; Coathup V; Teare H; Forgie I; Giordano GN; Hansen TH; Groeneveld L; Hudson M; Pearson E; Ruetten H; Kaye J
Genet Med; 2019 May; 21(5):1131-1138. PubMed ID: 30262927
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical industry-led partnerships focused on addressing the global burden of non-communicable diseases: a review of Access Accelerated.
Umeh CA; Rockers PC; Laing RO; Wagh O; Wirtz VJ
Public Health; 2020 Apr; 181():73-79. PubMed ID: 31958672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
